BLRX
BioLineRX
BLRX
BLRX
16 hedge funds and large institutions have $5.42M invested in BioLineRX in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$378K | |
| 2 | +$269K | |
| 3 | +$200K | |
| 4 |
Goldman Sachs
New York
|
+$65K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$32K |
Top Sellers
| 1 | -$124K | |
| 2 | -$79.8K | |
| 3 | -$77K | |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
-$5K |
| 5 |
RE
RBC Europe
London,
United Kingdom
|
-$17 |